3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: November 4, 2010
Period of Report: March 15, 2010
Accession Number: 0001019687-10-003929

View Document ↗ View on SEC.gov ↗